The Venus Times

The Venus Times

Sign in Subscribe

Accreditations & Approvals Featured

Venus Remedies Secures Coveted UNICEF Approval for Global Impact

Venus Remedies Limited, a leading pharmaceutical company with a global footprint, is proud to announce its recent attainment of Good Manufacturing Practices (GMP) approval from the United Nations Children's Fund (UNICEF). This approval signifies a significant milestone for the company, highlighting its unwavering commitment to delivering top-tier pharmaceutical solutions worldwide.

Venus Remedies | Government of India | PLI Scheme

Accreditations & Approvals Featured

Empowering Innovation: Venus Remedies Receives Incentive under Government's PLI Scheme

In a testament to its commitment to innovation and growth, Venus Remedies Limited proudly announces its successful acquisition of an incentive under the Government of India's Production Linked Incentive (PLI) scheme. The company has secured a substantial incentive amounting to ₹7.5 crore, representing 75% of the total incentive for

Union Budget 2024

Bulletin Featured

Pharma's Call for Innovation and Policy Support in Budget 2024

As we approach Budget 2024-2025, the pharmaceutical industry eagerly awaits pivotal decisions that will shape India's trajectory towards becoming the 'Pharmacy to the World' and embracing 'OneHealth' principles. Mr. Saransh Chaudhary, President of Global Critical Care at Venus Remedies Ltd and CEO of Venus Medicine Research Centre (VMRC), recently shared

Venus Remedies Receives GMP Certification from Libya

Accreditations & Approvals Featured

Venus Remedies Attains GMP Certification from Libya, Amplifying its Presence in Africa's Pharmaceutical Landscape

Venus Remedies has recently been awarded the prestigious Good Manufacturing Practices (GMP) certification by Libya. This certification is a testament to Venus Remedies' unwavering commitment to maintaining the highest standards of quality and safety in the pharmaceutical industry. The GMP certification from Libya reflects Venus Remedies' adherence to stringent guidelines

Venus Remedies Limited - GPTW

Awards Featured

Third Time's a Charm!!

Celebrating Excellence: Venus Remedies Secures Great Place to Work Certification for the Third Consecutive Year! Venus Remedies has once again achieved the prestigious Great Place to Work (GPTW) certification for the third consecutive year! As a company committed to cultivating an inclusive and positive workplace culture, this award is truly

Venus Remedies - Marketing Authorizations - Asia

Accreditations & Approvals

Venus Remedies Limited Receives Market Authorizations in Saudi Arabia and the Philippines

Venus Remedies Limited recently obtained regulatory approval for the marketing of three essential drugs in Saudi Arabia and the Philippines. In the dynamic region of Asia, Venus Remedies has received approval for Paclitaxel 100mg/16.7ml and Zoledronic Acid 4mg in the Philippines. These medications are crucial components in the

Venus Remedies - Azerbaijan - Enoxaparin

Accreditations & Approvals Featured

Venus Remedies Breaks New Ground with Marketing Authorization for Enoxaparin in Azerbaijan

Venus Remedies Limited, a pioneer in fixed-dosage injectable manufacturing, is proud to announce a major stride in its global expansion strategy. The company has achieved marketing authorization for Enoxaparin in Azerbaijan, marking its entry into this dynamic pharmaceutical market for the first time. Enoxaparin, a vital anticoagulant, plays a pivotal

Venus Remedies | Three Star Export House | Government of India

Accreditations & Approvals

Venus Remedies Attains the Coveted 'Three Star Export House' Certification from the Government of India!

Venus Remedies, a trailblazing pharmaceutical company, has achieved the prestigious 'Three Star Export House' certification from the Government of India, Ministry of Commerce and Industry, Directorate General of Foreign Trade. This remarkable accomplishment underscores Venus Remedies' unwavering commitment to excellence in international trade and its dedication to global health. From

Venus Remedies | FICCI Healthcare Awards

Awards Featured

Venus Remedies Honored with FICCI Healthcare Awards 2023!

Venus Remedies has once again demonstrated its commitment to excellence and innovation in the healthcare industry. Your company has been recognized by the Federation of Indian Chambers of Commerce and Industry (FICCI) Healthcare Awards 2023 in the "Excellence in Patient Care and Safety" category. This prestigious award further highlights the

CPhI Barcelona 2023

Events Featured

Venus Remedies Shines at CPhI Barcelona 2023

Barcelona, Spain - 24-26 October! Venus Remedies made a significant mark at the recently concluded CPhI Barcelona 2023, a premier global event for the pharmaceutical industry. The event, held in the vibrant city of Barcelona, brought together pharmaceutical professionals, companies, and experts from around the world. Venus Remedies showcased its

Venus Remedies - Bleomycin - MA from UK MHRA

Accreditations & Approvals Featured

Venus Remedies Celebrates Market Authorization for Bleomycin 15,000 IU in the UK

Venus Remedies is thrilled to announce a significant achievement in its ongoing mission to enhance cancer care with innovative solutions. The company's German subsidiary, Venus Pharma GmbH, has secured market authorization in the United Kingdom for Bleomycin 15,000 IU Powder for Solution for Injection/Infusion, marking a remarkable milestone

Venus Remedies | CII REO

Accreditations & Approvals Featured

Venus Remedies Receives CII Responsible Export Organization Certification for the Second Consecutive Year

Venus Remedies Limited has once again been honored with the prestigious CII Responsible Export Organization (REO) certification, marking a remarkable achievement for our organization. This recognition is a testament to our unwavering commitment to responsible business practices, sustainability, and excellence in every aspect of our operations. The CII Responsible Export

Cipla collaborates with Venus | AMR

Associations Featured

The Venus & Cipla Collaboration: Pioneering the Fight Against Antimicrobial Resistance (AMR)

Antimicrobial Resistance (AMR) stands as a formidable global health threat, with the World Health Organization (WHO) ranking it among the top 10 public health concerns. In the battle against this rising menace, pharmaceutical giants Venus Remedies and Cipla have joined forces, marking a significant stride in India's fight against AMR.

Venus Remedies | Philippines

Accreditations & Approvals Featured

Venus Remedies Secures Marketing Approval for Six Key Chemotherapy Drugs in the Philippines, Expands Presence in Thriving Pharma Market

Venus Remedies has achieved a significant milestone by obtaining marketing approval for six essential chemotherapy drugs in the Philippines. This development not only bolsters the company's presence in the global pharmaceutical market but also marks a promising advancement in the fight against cancer across Southeast Asia. Venus Remedies' unwavering dedication

Venus Remedies Elores Ecuador

The Grand Launch Featured

Venus Remedies Expands Its Global Footprint with the Launch of Elores in Ecuador

In a remarkable stride towards global healthcare excellence, Venus Remedies Limited proudly announces the successful launch of Elores in Ecuador. The achievement marks a significant milestone in our journey to combat multi-drug-resistant infections. Elores, an innovative antibiotic formulation, has garnered recognition and acclaim worldwide for its groundbreaking approach to tackling

Venus Remedies Limited - Best Working Conditions Award 2022 - Haryana State Safety, Health & Welfare Awards

Awards Featured

Venus Remedies Limited Receives Best Working Conditions Award 2022

Venus Remedies Limited, a renowned pharmaceutical company based in Panchkula, was honored with the "Best Working Conditions Award 2022" on the occasion of Rajkiya Shramik Divas. This prestigious award was presented by Shri Manohar Lal Khattar, the Chief Minister of Haryana, as part of the Haryana State Safety, Health, and

VMRC - Venus Medicine Research Center

Accreditations & Approvals Featured

Venus Remedies Expands Oncology Portfolio in Eastern Europe with Serbian Marketing Approval

Bringing forth the latest update from the world of pharmaceuticals. Venus Remedies, a renowned name in the pharma industry, has recently achieved a significant milestone by securing marketing approval in Serbia for two crucial cancer drugs, gemcitabine and docetaxel. This expansion is a testament to Venus Remedies' commitment to advancing

Venus Remedies Limited - Enoxaparin - Saudi Arabia

Accreditations & Approvals Featured

Venus Remedies Secures Marketing Approval for Enoxaparin in Saudi Arabia

In a Remarkable Milestone, Venus Remedies' Enoxaparin Prefilled Syringes Gain Marketing Approval in Saudi Arabia We are delighted to share some exciting news that underscores Venus Remedies' commitment to advancing healthcare worldwide. Venus Remedies has recently achieved a significant milestone by securing marketing approval for its Enoxaparin Prefilled Syringes in

The Grand Launch

Venus Remedies Unveils Flagship R&D Drug, Elores, in Oman

In a momentous move, Venus Remedies, a pioneer in the pharmaceutical industry, has announced the launch of its flagship Research & Development product, 'Elores', in the Sultanate of Oman. This groundbreaking product promises to set new standards in the antibiotic segment and showcases the company's relentless pursuit of innovative solutions in

Mr. Saransh Chaudhary

Publications Featured

Special Feature: Insights from Our CEO, VMRC, Mr. Saransh Chaudhary

We are thrilled to share that Mr. Saransh Chaudhary, President of Global Critical Care at Venus Remedies, has been prominently featured in the Anniversary Issue of the prestigious Pharma Bio World (PBW) magazine. Highlights from the feature: 1. Reimagining Business Models: The special edition delves deep into how industry leaders

Cancer Medicine

Accreditations & Approvals Featured

Venus Remedies Bags Four More Market Authorisations for Cancer Drugs!

Hot on the heels of our recent achievements, Venus Remedies is thrilled to announce yet another significant accomplishment. We have secured market authorisations for our pioneering cancer drugs from the Philippines, Paraguay, Georgia, and Moldova. This new stride not only reinforces our commitment to spearheading global oncology solutions but also

Accreditations & Approvals Featured

Expanding Our Oncology Wing: Four Major Market Approvals

We're thrilled to announce that Venus Remedies has achieved a significant milestone in our commitment to providing top-tier oncology solutions worldwide. 🔹 Key Highlights: 1. Marketing Approvals from Four Key Markets: We have secured marketing approvals for our chemotherapy drugs from Oman, Malaysia, Bosnia, and Trinidad & Tobago. 2. These approvals mark

Business World on Antibiotics

Publications Featured

Saransh Chaudhary, President, GCC & CEO, VMRC Shares Insights on Innovative R&D in Antibiotics with Business World

In the ever-evolving medical landscape, antibiotic resistance, known as Antimicrobial Resistance (AMR), poses one of the most significant global challenges. In a testament to Venus Remedies' commitment to pioneering advancements in medical science, our esteemed President of Global Critical Care, Mr. Saransh Chaudhary, was featured in Business World's edition dated

Dr. Manu Chaudhary

Publications Featured

Meropenem: The Powerful Antibacterial Solution for Effective Treatment

Shining a spotlight on an essential antibacterial drug called Meropenem, which has revolutionized the field of medicine, this news piece brings forth a recently published article about Meropenem at TheHealthSite.com. It highlights the insightful information on the drug as shared by Dr. Manu Chaudhary, Director, Research, Venus Remedies. Meropenem,